Treatment of hypereosinophilic syndrome and eosinophilic dermatitis with reslizumab.

Authors :: Kuruvilla M
Source :: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology [Ann Allergy Asthma Immunol] 2018 Jun; Vol. 120 (6), pp. 670-671. Date of Electronic Publication: 2018 Feb 26.
Publication Year :: 2018

Subjects :: Cellulitis genetics
Cellulitis immunology
Cellulitis pathology
Dermatitis genetics
Dermatitis immunology
Dermatitis pathology
Eosinophilia genetics
Eosinophilia immunology
Eosinophilia pathology
Eosinophilic Esophagitis genetics
Eosinophilic Esophagitis immunology
Eosinophilic Esophagitis pathology
Eosinophils drug effects
Eosinophils immunology
Eosinophils pathology
Female
Gene Expression
Glucocorticoids therapeutic use
Humans
Hypereosinophilic Syndrome genetics
Hypereosinophilic Syndrome immunology
Hypereosinophilic Syndrome pathology
Interleukin-5 antagonists & inhibitors
Interleukin-5 genetics
Interleukin-5 immunology
Middle Aged
Prednisone therapeutic use
Antibodies, Monoclonal, Humanized therapeutic use
Cellulitis drug therapy
Dermatitis drug therapy
Eosinophilia drug therapy
Eosinophilic Esophagitis drug therapy
Hypereosinophilic Syndrome drug therapy
Immunologic Factors therapeutic use

Language :: English
ISSN :: 1534-4436
Volume :: 120
Issue :: 6
Database :: MEDLINE
Journal :: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Publication Type :: Academic Journal
Accession number :: 29496465
Full Text :: https://doi.org/10.1016/j.anai.2018.02.017

Full Text Access

Tools